Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease

Cerebrospinal fluid β-amyloid 42 and neurofilament light relate to white matter hyperintensities

(2018) Katie E. Osborn et al.   NEUROBIOLOGY OF AGING

Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer’s Disease and Mild Cognitive Impairment: A Two-year Follow-up Study

(2018) Wei-Ju Lee et al.   Scientific Reports

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

(2017) Lauren M Byrne et al.   LANCET NEUROLOGY

CSF neurofilament light levels predict hippocampal atrophy in cognitively healthy older adults

(2017) Ane-Victoria Idland et al.   NEUROBIOLOGY OF AGING

Blood-based NfL

(2017) Oskar Hansson et al.   NEUROLOGY

Plasma neurofilament light chain levels in Alzheimer’s disease

(2017) Wenjun Zhou et al.   NEUROSCIENCE LETTERS

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

(2017) Niklas Mattsson et al.   JAMA Neurology

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

(2016) Jens Kuhle et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Association of Apolipoprotein E (ApoE) Polymorphism with Alzheimer';s Disease in Chinese Population

(2016) Lingling Zheng et al.   Current Alzheimer Research

Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson’s disease

(2016) Yaqian Xu et al.   JOURNAL OF NEUROLOGY

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia

(2016) Jonathan D. Rohrer et al.   NEUROLOGY

Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases

(2016) Mehtap Bacioglu et al.   NEURON

SORL1 gene, plasma biomarkers, and the risk of Alzheimer’s disease for the Han Chinese population in Taiwan

(2016) Cheng-Ta Chou et al.   Alzheimers Research & Therapy

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

(2016) Magnus Gisslén et al.   EBioMedicine

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis

(2015) C.-H. Lu et al.   NEUROLOGY

Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction

(2015) Mattias Vågberg et al.   PLoS One

Brain volumetry in Parkinson's disease with and without dementia: where are the differences?

(2013) Seung-Hwan Lee et al.   ACTA RADIOLOGICA

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

CSF biomarkers in neurodegenerative diseases

(2011) Niklas Mattsson   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

White matter lesions in Parkinson disease

(2011) Nicolaas I. Bohnen et al.   Nature Reviews Neurology

Correlations between MRI white matter lesion location and executive function and episodic memory

(2011) E. E. Smith et al.   NEUROLOGY

The heterogeneity of mild cognitive impairment: A neuropsychological analysis

(2009) DAVID J. LIBON et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS

Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease

(2008) Radu Constantinescu et al.   PARKINSONISM & RELATED DISORDERS